Lactulose for the Prevention of Nosocomial Infections in Children

• Status: Unknown status
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the ability of lactulose, a prebiotic agent, to prevent hospital acquired infection in children

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bnai Zion Medical Center
• Treatments: Lactulose

Criteria

Inclusion Criteria:

• All children aged 2 to 36 months who are admitted to the hospital for reasons other than diarrhea will be eligible for the study.

Exclusion Criteria:

• Children with a history of probiotics or prebiotics use within 7 days before admission, acute gastroenteritis within 3 days before admission, vomiting, treated chronic constipation, known anatomic problem in the gastrointestinal tract will be excluded from the study.